Mechanism of MMP-2-selective inhibitory action of β-amyloid precursor protein-derived inhibitor and its application to design specific inhibitors against individual MMPs
1) Miyazaki K, Hasegawa M, Funahashi K, Umeda M: A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature 362: 839-841, 1993.
2) Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
3) Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995.
4) Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W: Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81, 1997.
5) Higashi S, Miyazaki K: Reactive site-modified tissue inhibitor of metalloproteinases-2 inhibits the cell-mediated activation of progelatinase A. J Biol Chem 274: 10497-10504, 1999.